USA – Diversified commodity-processing company, Green Plains has entered into an exclusive partnership with Danish company, Novozymes for biological solutions in the production of high protein ingredients.
The partnership will be aimed at aquaculture, pet food, as well as novel ingredients to be used in the global protein markets.
The collaboration will utilize the biorefinery footprint, process know-how, and global distribution capabilities of Green Plains together with Novozymes’ expertise in microbiology to create a diverse range of value-added products resulting in functional proteins.
Novozymes will combine its biological solutions with Green Plains’ first high protein production facility and Optimal Aquafeed’s aquaculture laboratory in Shenandoah, Iowa, USA.
According to a statement from the companies, the intention is to create one of the leading end-to-end innovation platforms in the world for aquaculture nutrition.
Todd Becker, president and chief executive officer of Green Plains said, “This exclusive technology partnership is another step in the transformation of Green Plains to a world class protein provider.
“By partnering with Novozymes, we believe we will be able to increase the value of the products we produce every day and together provide solutions for our nutritional partners in the aquaculture, animal feed, and companion animal food markets worldwide.”
Brian Brazeau, Novozymes’ VP for Bioenergy Commercial and President of North America added: “We are really excited to further utilize advanced biology to unlock additional commercial opportunities in protein production in biorefining together with our customers.
“In line with our updated strategy, the partnership with Green Plains is yet another example of how we use enzymatic and microbial solutions to help bring biological answers to the challenge and opportunity of growth in global protein demand.”
Green Plains said that Novozymes’ existing suite of biotechnology will help the company to achieve higher concentrations of protein.
As part of the agreement, Novozymes will dedicate R&D resources to explore new techniques of testing Green Plains processes to further enhance protein products and ultimately create different, higher value outputs from Green Plains’ biofuels production facilities.
“As we continue to roll out high protein nutritional solutions for our customers, we expect to create a company with predictable and growing earnings and become much less dependent on our traditional business structure,” added Becker.
“This will extend Novozymes’ reach into the agricultural supply chain as our biological solutions will touch a much larger portion of the animal feed market,” Brazeau further added.
“The collaboration will enable better business for our customers and help meet the need for evermore protein.”
The companies plan to begin implementation of the partnership in the first quarter of 2020.
